Treatment with Etanercept did not alter VDR expression on CD3+ and CD14+ cells in patients with psoriasis over the 24-week period (p = 0.99, p = 0.96) (Figure 1 and Figure 2). This evidence concerns the gene CD14 and psoriasis.